Hepatic metastases: In vivo assessment of perfusion parameters at dynamic contrast-enhanced MR imaging with dual-input two- compartment tracer kinetics model1

Radiology

Volumn 249, Issue 1, 2008, Pages 307-320

  Koh, Tong San ^a   Thng, Choon Hua ^b   Lee, Puor Sherng ^b   Hartono, Septian ^a,b   Rumpel, Helmut ^c   Goh, Boon Cher ^d   Bisdas, Sotirios ^e  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^b DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^c SINGAPORE GENERAL HOSPITAL   (Singapore)

^d NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^e UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; GADODIAMIDE; TRACER;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IN VIVO STUDY; INFORMATION PROCESSING; LIVER METASTASIS; LIVER PARENCHYMA; LIVER PERFUSION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; LIVER TUMOR; METASTASIS; METHODOLOGY; MIDDLE AGED; THEORETICAL MODEL; VASCULARIZATION;

FEMALE; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MODELS, THEORETICAL; RETROSPECTIVE STUDIES;

EID: 53749095872     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2483071958     Document Type: Article

References (41)

1. Chiandussi L, Greco F, Sardi G, Vaccarino A, Ferraris CM, Curti B. Estimation of hepatic arterial and portal venous blood flow by direct catheterization of the vena porta through the umbilical cord in man: preliminary results. Acta Hepatosplenol 1968;15: 166-171.
2. Schenk WG Jr, McDonald JC, McDonald K, Drapanas T. Direct measurement of hepatic blood flow in surgical patients: with related observations on hepatic flow dynamics in experimental animals. Ann Surg 1962;156: 463-471.
3. Matsui O, Takashima T, Kadoya M, et al. Liver metastases from colorectal cancers: detection with CT during arterial portography. Radiology 1987;165:65-69.
4. Lin G, Lunderquist A, Hagerstrand I, Boijsen E. Postmortem examination of the blood supply and vascular pattern of small liver metastases in man. Surgery 1984;96:517-526.
5. Liu Y, Matsui O. Changes of intratumoral microvessels and blood perfusion during establishment of hepatic metastases in mice. Radiology 2007;243:386-395.
6. Foley WD. Dynamic hepatic CT. Radiology 1989;170:617-622.
7. Garrean S, Hering J, Helton WS, Espat NJ. A primer on transarterial, chemical, and thermal ablative therapies for hepatic tumors. Am J Surg 2007;194:79-88.
8. Nanashima A, Yamaguchi H, Sawai T, et al. Prognostic factors in hepatic metastases of colorectal carcinoma. Dig Dis Sci 2001;46:1623-1628.
9. Vermeulen PB, Roland L, Mertens V, et al. Correlation of intratumoral microvessel density and p53 protein overexpression in human colorectal adenocarcinoma. Microvasc Res 1996;51:164-174.
10. Annet L, Materne R, Danse E, Jamart J, Horsmans Y, Van Beers BE. Hepatic flow parameters measured with MR imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension. Radiology 2003;229:409-414.
11. Materne R, Smith AM, Peeters F, et al. Assessment of hepatic perfusion parameters with dynamic MRI. Magn Reson Med 2002; 47:135-142.
12. Materne R, Van Beers BE, Smith AM, et al. Non-invasive quantification of liver perfusion with dynamic computed tomography and a dual-input one-compartmental model. Clin Sci 2000;99:517-525.
13. Van Beers BE, Leconte I, Materne R, Smith AM, Jamart J, Horsmans Y. Hepatic perfusion parameters in chronic liver disease: dynamic CT measurements correlated with disease severity. AJR Am J Roentgenol 2001;176:667-673.
14. Scharf J, Zapletal C, Hess T, et al. Assessment ofhepatic perfusion inpigs by pharma-cokinetic analysis of dynamic MR images. J Magn Reson Imaging 1999;9:568-572.
15. Larson KB, Markham J, Raichle ME. Tracer-kinetic models for measuring cerebral blood flow using externally detected radiotracers. J Cereb Blood Flow Metab 1987;7:443-463.
16. KohTS, Cheong LH, HouZ, Soh YC. A physiologic model ofcapillary-tissue exchange for dynamic contrast-enhanced imaging of tumor microcirculation. IEEE Trans Biomed Eng 2003;50:159-167.
17. Pandharipande PV, Krinsky GA, Rusinek H, Lee VS. Perfusion imaging of the liver: current challenges and future goals. Radiology 2005;234:661-673.
18. Renkin EM. Transport of potassium-42 from blood to tissue in isolated mammalian skeletal muscles. Am J Physiol 1959;197:1205-1210.
19. Crone C. The permeability of brain capillaries to non-electrolytes. Acta Physiol Scand 1965;64:407-417.
20. Koh TS. On the a priori identifiability of the two-compartment distributed parameter model from residual tracer data acquired by dynamic contrast-enhanced imaging. IEEE Trans Biomed Eng 2008;55:340-344.
21. Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T1-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999;10:223-232.
22. Brookes JA, Redpath TW, Gilbert FJ, Needham G, Murray AD. Measurement of spinlattice relaxation times with FLASH for dynamic MRI of the breast. Br J Radiol 1996;69:206-214.
23. Friston KJ, Ashburner J, Frith CD, Poline JB, Heather JD, Frackowiak RS. Spatial registration and normalization of images. Hum Brain Mapp 1995;3:165-189.
24. Brix G, Kiessling F, Lucht R, et al. Microcirculation and microvasculature in breast tumors: pharmacokinetic analysis of dynamic MR image series. Magn Reson Med 2004;52:420-429.
25. Shuter B, Tofts PS, Wang SC, Pope JM. The relaxivity ofGd-EOB-DTPA and Gd-DTPA in liver and kidney of the Wistar rat. Magn Reson Imaging 1996;14:243-253.
26. Zhang JL, Koh TS. On the selection of optimal flip angles for T1 mapping of breast tumors with dynamic contrast-enhanced magnetic resonance imaging. IEEETrans Biomed Eng 2006;53:1209-1214.
27. Tsushima Y, Funabasama S, Aoki J, Sanada S, Endo K. Quantitative perfusion map of malignant liver tumors, created from dynamic computed tomography data. Acad Radiol 2004;11:215-223.
28. Tsushima Y, Blomley MJ, Yokoyama H, Kusano S, Endo K. Does the presence of distant and local malignancy alter parenchymal perfusion in apparently disease-free areas of the liver? Dig Dis Sci 2001;46:2113-2119.
29. Platt JF, Francis IR, Ellis JH, Reige KA. Difference in global hepatic enhancement assessed by dynamic CT in normal subjects and patients with hepatic metastases. J Comput Assist Tomogr 1997;21:348-354.
30. Platt JF. Liver metastases: early detection based on abnormal contrast material enhancement at dual-phase helical CT. Radiology 1997;205:49-53.
31. Leggett DA, Kelley BB, Bunce IH, Miles KA. Colorectal cancer: diagnostic potential of CT measurements of hepatic perfusion and implications for contrast enhancement protocols. Radiology 1997;205:716-720.
32. Sheafor DH, Killius JS, Paulson EK, DeLong DM, Foti AM, Nelson RC. Hepatic parenchymal enhancement during triple-phase helical CT: can it be used to predict which patients with breast cancer will develop hepatic metastases? Radiology 2000;214:875-880.
33. Outwater E, Tomaszewski JE, Daly JM, Kressel HY. Hepatic colorectal metastases: correlation of MR imaging and pathologic appearance. Radiology 1991;180:327-332.
34. Blomley MJ, Coulden R, Dawson P, et al. Liver perfusion studied with ultrafast CT. J Comput Assist Tomogr 1995;19:424-433.
35. Miles KA, Leggett DA, Kelley BB, Hayball MP, Sinnatamby R, Bunce I. In vivo assessment of neovascularization of liver metastases using perfusion CT. Br J Radiol 1998;71: 276-281.
36. ScharfJ, Kemmling A, Hess T, et al. Assessment of hepatic perfusion in transplanted livers by pharmacokinetic analysis of dynamic magnetic resonance measurements. Invest Radiol 2007;42:224-229.
37. Lee TY, Purdie TG, Stewart E. CT imaging of angiogenesis. Q J Nucl Med 2003;47:171-187.
38. St Lawrence KS, Lee TY. An adiabatic approximation to the tissue homogeneity model for water exchange in the brain. I. Theoretical derivation. J Cereb Blood Flow Metab 1998;18:1365-1377.
39. Morgan B, Thomas AL, Drevs J, et al. Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer and liver metastases: results from two phase I studies. J Clin Oncol 2003;21:3955-3964.
40. Jain RK. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 2005;307:58-62.
41. Orton MR, Collins DJ, Walker-Samuel S, et al. Bayesian estimation of pharmacokinetic parameters for DCE-MRI with a robust treatment of enhancement onset time. Phys Med Biol 2007;52:2393-2408.